During the past decade, Stony Brook University Cancer Center conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 40 clinical trials were completed, i.e. on average, 105.3% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 14 clinical trials were completed. i.e. 77.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Stony Brook University Cancer Center" #1 sponsor was "Children's Oncology Group" with 26 trials, followed by "Alliance for Clinical Trials in Oncology" with 14 trials sponsored, "Gynecologic Oncology Group" with 12 trials sponsored, "Pfizer" with 10 trials sponsored and "Stony Brook University" with 10 trials sponsored. Other sponsors include 42 different institutions and companies that sponsored additional 36 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Stony Brook University Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 68 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator and "Bristol-Myers Squibb" with 2 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Stony Brook University Cancer Center" are "Leukemia" (12 trials), "Breast Cancer" (10 trials), "Lung Cancer" (10 trials), "Sarcoma" (8 trials) and "Lymphoma" (6 trials). Many other conditions were trialed in "Stony Brook University Cancer Center" in a lesser frequency.

Most popular intervention types in "Stony Brook University Cancer Center" are "Drug" (89 trials), "Biological" (30 trials), "Radiation" (25 trials), "Procedure" (20 trials) and "Other" (12 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (16 trials), "filgrastim" (15 trials), "radiation therapy" (14 trials), "cytarabine" (12 trials) and "vincristine sulfate" (12 trials). Other intervention names were less common.

The vast majority of trials in "Stony Brook University Cancer Center" are 89 trials for "All" genders, 24 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Stony Brook University Cancer Center". undefined are not yet recruiting, 11 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 79 completed trials in Stony Brook University Cancer Center, 1 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Stony Brook University Cancer Center, 4 "Phase 1" clinical trials were conducted, 48 "Phase 2" clinical trials and 52 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".